| Year |
Citation |
Score |
| 2015 |
Frenssen F, Croonenberghs J, Van den Steene H, Maes M. Prolyl endopeptidase and dipeptidyl peptidase IV are associated with externalizing and aggressive behaviors in normal and autistic adolescents. Life Sciences. 136: 157-62. PMID 26165750 DOI: 10.1016/J.Lfs.2015.07.003 |
0.348 |
|
| 2010 |
Croonenberghs J, Van Grieken S, Wauters A, Van West D, Brouw L, Maes M, Deboutte D. Serum testosterone concentration in male autistic youngsters. Neuro Endocrinology Letters. 31: 483-8. PMID 20802443 |
0.67 |
|
| 2008 |
Croonenberghs J, Spaas K, Wauters A, Verkerk R, Scharpe S, Deboutte D, Maes M. Faulty serotonin--DHEA interactions in autism: results of the 5-hydroxytryptophan challenge test. Neuro Endocrinology Letters. 29: 385-90. PMID 18580847 |
0.614 |
|
| 2007 |
Croonenberghs J, Wauters A, Deboutte D, Verkerk R, Scharpe S, Maes M. Central serotonergic hypofunction in autism: results of the 5-hydroxy-tryptophan challenge test. Neuro Endocrinology Letters. 28: 449-55. PMID 17693983 |
0.68 |
|
| 2007 |
Nordin P, Croonenberghs J, Deboutte D. The treatment of early-onset schizophrenia Tijdschrift Voor Geneeskunde. 63: 870-878. DOI: 10.2143/TVG.63.18.2000159 |
0.521 |
|
| 2006 |
Sliwinski S, Croonenberghs J, Christophe A, Deboutte D, Maes M. Polyunsaturated fatty acids: do they have a role in the pathophysiology of autism? Neuro Endocrinology Letters. 27: 465-71. PMID 16891996 |
0.558 |
|
| 2006 |
Reyes M, Croonenberghs J, Augustyns I, Eerdekens M. Long-term use of risperidone in children with disruptive behavior disorders and subaverage intelligence: efficacy, safety, and tolerability. Journal of Child and Adolescent Psychopharmacology. 16: 260-72. PMID 16768634 DOI: 10.1089/Cap.2006.16.260 |
0.324 |
|
| 2005 |
Croonenberghs J, Verkerk R, Scharpe S, Deboutte D, Maes M. Serotonergic disturbances in autistic disorder: L-5-hydroxytryptophan administration to autistic youngsters increases the blood concentrations of serotonin in patients but not in controls. Life Sciences. 76: 2171-83. PMID 15733932 DOI: 10.1016/J.Lfs.2004.06.032 |
0.64 |
|
| 2005 |
Croonenberghs J, Fegert JM, Findling RL, De Smedt G, Van Dongen S. Risperidone in children with disruptive behavior disorders and subaverage intelligence: a 1-year, open-label study of 504 patients. Journal of the American Academy of Child and Adolescent Psychiatry. 44: 64-72. PMID 15608545 DOI: 10.1097/01.Chi.0000145805.24274.09 |
0.317 |
|
| 2005 |
Croonenberghs J, Findling RL, Reyes M, Karcher K. ANTIPSYCHOTICS IN DISRUPTIVE BEHAVIOR DISORDERS AND ADHD Journal of the American Academy of Child & Adolescent Psychiatry. 44: 970-971. DOI: 10.1097/01.Chi.0000172550.33973.6C |
0.359 |
|
| 2002 |
Casaer P, Croonenberghs JA, Lagae L, Deboutte D. Risperidone in the treatment of childhood autistic disorder: an open pilot study. Acta Neuropsychiatrica. 14: 242-9. PMID 26984464 DOI: 10.1034/J.1601-5215.2002.140508.X |
0.587 |
|
| 2002 |
Croonenberghs J, Deboutte D, Maes M. Pathophysiology of autism: current opinions. Acta Neuropsychiatrica. 14: 93-102. PMID 26983973 DOI: 10.1034/J.1601-5215.2002.140209.X |
0.598 |
|
| 2002 |
Croonenberghs J, Wauters A, Devreese K, Verkerk R, Scharpe S, Bosmans E, Egyed B, Deboutte D, Maes M. Increased serum albumin, gamma globulin, immunoglobulin IgG, and IgG2 and IgG4 in autism. Psychological Medicine. 32: 1457-63. PMID 12455944 DOI: 10.1017/S0033291702006037 |
0.621 |
|
| 2002 |
Croonenberghs J, Bosmans E, Deboutte D, Kenis G, Maes M. Activation of the inflammatory response system in autism. Neuropsychobiology. 45: 1-6. PMID 11803234 DOI: 10.1159/000048665 |
0.579 |
|
| 2000 |
Croonenberghs J, Delmeire L, Verkerk R, Lin AH, Meskal A, Neels H, Van der Planken M, Scharpe S, Deboutte D, Pison G, Maes M. Peripheral markers of serotonergic and noradrenergic function in post-pubertal, caucasian males with autistic disorder. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 22: 275-83. PMID 10693155 DOI: 10.1016/S0893-133X(99)00131-1 |
0.671 |
|
| Show low-probability matches. |